WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004033460) 5-CYCLOALKENYL 5H-CHROMENO[3,4-F]QUINOLINE DERIVATIVES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/033460    International Application No.:    PCT/US2003/024419
Publication Date: 22.04.2004 International Filing Date: 04.08.2003
Chapter 2 Demand Filed:    05.05.2004    
IPC:
C07D 491/04 (2006.01)
Applicants: LIGAND PHARMACEUTICALS INCORPORATED [US/US]; 10275 Science Center Drive, San Diego, CA 92121-1117 (US) (For All Designated States Except US).
ZHI, Lin [US/US]; (US) (For US Only).
VAN OEVEREN, Cornelis, Arjan [NL/US]; (US) (For US Only).
PEDRAM, Bijan [CA/US]; (US) (For US Only).
KARANEWSKY, Donald [US/US]; (US) (For US Only)
Inventors: ZHI, Lin; (US).
VAN OEVEREN, Cornelis, Arjan; (US).
PEDRAM, Bijan; (US).
KARANEWSKY, Donald; (US)
Agent: SEIDMAN, Stephanie, L.; FISH & RICHARDSON P.C., 12390 El Camino Real, San Diego, CA 92130 (US).
VIERING, JENTSCHURA & PARTNERS; Steindorfstr. 6, 80538 München (DE)
Priority Data:
60/417,975 11.10.2002 US
Title (EN) 5-CYCLOALKENYL 5H-CHROMENO[3,4-F]QUINOLINE DERIVATIVES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS
(FR) DERIVES DE 5-CYCLOALCENYLE 5H-CHROMENO[3,4-F]QUINOLINE SERVANT DE COMPOSES MODULATEURS SELECTIFS DU RECEPTEUR DE LA PROGESTERONE
Abstract: front page image
(EN)The present invention is directed to compounds, pharmaceutical compositions, and methods for modulating processes mediated by Progesterone Receptor. Also provided are methods of making such compounds and pharmaceutical compositions.
(FR)La présente invention se rapporte à des composés, à des compositions pharmaceutiques et à des procédés de modulation des procédés induits par le récepteur de la progestérone. Font également l'objet de cette invention des procédés de fabrication desdits composés et compositions pharmaceutiques.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)